Jan 20, 2021 - Health

Vaccine trials for children could produce data by summer

Illustration of syringes forming a health plus/cross
Illustration: Eniola Odetunde/Axios

Ongoing trials may produce data by this summer to indicate whether the vaccines are safe for children, Bloomberg reports.

Why it matters: Children generally aren't at risk of serious coronavirus infections, but vaccinating them will be key to protecting the adults around them and, eventually, reaching herd immunity.

Details: Pfizer and Moderna began recruiting participants for their clinical trials late last year.

  • The University of Oxford, which developed a vaccine with AstraZeneca, is planning to begin tests in 12-to-18-year-olds next month, and Johnson & Johnson will likely begin trials shortly after receiving results from its adult studies.
  • Clinical trials for children generally begin with teenagers and then work their way down to younger ages.

What we're watching: The sooner children have a vaccine, the sooner schools and child care can go back to normal, which will greatly ease the burden on millions of parents.

Go deeper